Potency-enhancing drugs linked to decreased risks in men with colorectal cancer
Published 17 August 2020 Wuqing Huang and Jianguang Ji A new study from Lund University and Region Skåne in Sweden indicates that potency-enhancing PDE5 inhibitor drugs have an anti-cancer potential with the ability to improve the prognosis in patients with colorectal cancer. PDE5 inhibitors include a few approved drugs in which sildenafil (Viagra) is the most well-known. The article is published
https://www.lunduniversity.lu.se/article/potency-enhancing-drugs-linked-decreased-risks-men-colorectal-cancer - 2025-07-05